Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes

Although clozapine has demonstrated superior efficacy in patients with schizophrenia and other serious mental health illness, drug utilization rates are significantly low due to safety concerns and administration challenges. Previous research indicates that current barriers to clozapine use include...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaria, Shamir N, Kelly, Deanna L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708436/
https://www.ncbi.nlm.nih.gov/pubmed/31692521
http://dx.doi.org/10.2147/NDT.S216803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708436/
https://www.ncbi.nlm.nih.gov/pubmed/31692521
http://dx.doi.org/10.2147/NDT.S216803

Ejemplares similares